Tobacco Use Disorder Clinical Trial
Official title:
Financial Incentive Structures for Smoking Cessation: A Pilot Randomized Trial
Financial incentives may be more effective than other approaches to smoking cessation, but
research is needed to identify the optimal structures of incentives. The investigators will
conduct a pilot randomized trial comparing different incentive structures for smoking
cessation. Collaborating with Walgreens leadership, the investigators will enroll their
employees in this RCT using the investigators new web-based research infrastructure (called
the Way to Health platform, and approved as a Prime protocol by the IRB as reference #
811860).
Hypothesis: providing patients with financial incentives can promote healthier behaviors
(e.g.: quit smoking).
This study is designed to explore the potential efficacy of using internet-based incentive
programs to promote smoking cessation. We also hope to document that we can recruit
participants through a web site, as well as investigate what forms of incentives show the
most promise. We seek to achieve three specific objectives: (1) assess our ability to
recruit participants for several different types of intervention-based smoking programs; (2)
document the feasibility of using the internet to accrue and disburse incentive payments;
(3) obtain preliminary assessments of which incentive structures show the most promise for
future study.
Potential participants will be directed to the Way to Health research portal and will be
assessed for eligibility. The web application will automatically verify eligibility based on
the results of the survey. If a person is deemed eligible, he or she will be invited to
consent to participate in a non-pharmacologic smoking cessation study lasting 3 months.
Participants who consent will be randomized automatically to one of the 5 intervention arms
(including the no-incentive arm) by the web application.
Once the participant consents and submits the necessary financial information, he will gain
access to the participant interface. At this point, they will receive detailed descriptions
of their assigned incentive structures (or usual care provisions), will indicate their
acceptance of their assigned structure and, for those in arms 3, 4, or 5, make their
required deposits. Also, he will be prompted to take an initial survey on his baseline
smoking habits. The participant will be able to log into this interface at anytime and see a
graph of his self-reported smoking habits along with a graph of approximately how much money
he has saved compared to his baseline smoking levels. Participants will indicate their
preferred method of contact: email, text-messaging, or both. Every week the participant will
receive an email or text-message reminder to log in and complete a weekly smoking report.
Participants can also log in at any time and report on their smoking habits for a given day
or days to improve accuracy. After three months all subjects will be e-mailed to prompt them
to log into the web application to take a final smoking habits survey. Participants who
report having remained smoke free for the last month of the study will submit saliva (or
urine, for participants using any form of nicotine replacement therapy) samples to test for
cotinine (or anabasine) to verify that they have quit. Once this has been verified, the
participant will be sent whatever financial incentives he has earned and any deposit will be
returned.
The design of this study differs from a traditional RCT in two important ways. First,
because the goal of this RCT is to focus on mechanisms of behavior change, we include a
primary per-protocol analysis designed to determine incentive structures' efficacy by
analyzing only participants who accept their assigned incentive structure at the time of
randomization. In this analysis, the randomization arm will be entered into the analytic
model as an instrumental variable to mitigate potential selection bias. As in a traditional
RCT, we will also analyze each incentive structures' effectiveness using an
intention-to-treat analysis that includes all randomized participants, regardless of whether
they accept the randomly assigned arm. The second difference is that because acceptance
rates of the different structures may differ (as we will test in Aim II), we will adapt the
probabilities of being randomized to each arm on a weekly basis during the enrollment period
to achieve the target numbers of participants in the per-protocol analysis.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00158158 -
Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
|
Phase 2/Phase 3 | |
Completed |
NCT00218179 -
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
|
N/A | |
Completed |
NCT01213524 -
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
|
Phase 2 |